Califf Nomination Adds New Dynamic, Maybe New Provisions, To FDA Reform Bills
Senate legislation may be influenced by movement to push through Califf’s nomination for FDA commissioner.
You may also be interested in...
Califf Nomination May Show Confidence In His Bipartisan Appeal
After seven months as deputy commissioner for medical products and tobacco, Robert Califf tapped to be FDA Commissioner.
PDUFA Budgeting: What Will Get Added, Subtracted – Or Multiplied By Cures?
Industry official sees potential for some streamlining in user fee program, but adding to breakthrough and patient-centered activities seems most likely.
Senator Tells FDA To Create ‘Red Team’ For Regulatory Streamlining
HELP Committee Chairman Lamar Alexander wants FDA to suggest regs and other bureaucratic requirements that are hindering productivity as part of medical innovation effort.